17-06-2012 23:59 Gary B Stem Cell Therapy for CMT Part 2 - For more info. visit Read more here: Stem Cell Therapy for CMT-Gary B-part 2.mp4 - Video … Continue reading →

BOSTON--(BUSINESS WIRE)-- Sistemic Ltd., a leading provider of microRNA-based problem-solving services and kit-based products to the Cell Therapy community, announced today that chairman and CEO Jim Reid is moderating a panel discussion at the 2012 Bio International Convention on Wednesday, June 20, in Boston. Featuring leaders from the regenerative medicine space, the panel is titled Stem Cell Therapies Fact or Fiction, and will share the lessons learned to-date from Scottish, European and American perspectives on the path to successfulcommercialization of stem cell therapies. Jim Reid, Sistemic CEO, commented, "Sistemic is very active in the CellTherapyarena and aremembersof Alliance for Advanced Therapies (AAT) and the Alliance for Regenerative Medicine (ARM). We see the ability to raise this topic at the leading world event, BIO 2012, as animportantstep on the path to commercialization of these products which will be transformational in healthcare, and bring hope and cures to many people around the globe." More information on the panel at BIO 2012: What: Panel Discussion Featuring Leaders in the Regenerative Medicine Space When: Wednesday, June 20, 3:00PM EDT Where: Boston Convention Center, Room 254A Who: Leaders of the Regenerative Medicine space: Panel objectives include evaluating lessons learned and best practice including from the … Continue reading →

Gov. Dannel P. Malloy Monday announced $9.8 million in grants to 19 stem cell research projects in the state. The Connecticut Stem Cell Research Advisory Committee had selected the recipients at its grant review meeting last Tuesday in Farmington. "Connecticut's continued support of stem cell research has allowed for exciting and innovative research to take place right here in our state," Malloy said in a statement. "The research projects funded by these grants allow scientists to do revolutionary work that puts Connecticut at the forefront of bioscience industry." Of the 19 grants, 13 grants totaling $7.25 million were awarded to Yale scientists, five went to University of Connecticut researchers, and one went to a collaboration between Wesleyan and UConn scientists. The largest grant, $1.8 million, was awarded to D. Eugene Redmond of Yale. Redmond has focused on cellular repair in the nervous system and how it relates to Parkinson's disease. UConn's Stormy Chamberlain, an assistant professor of genetics and developmental biology at the UConn Health Center, received a $450,000 grant to develop new therapies for Prader-Willi syndrome and Angelman Syndrome, both rare genetic disorders. Children born with Prader-Willi Syndrome have difficulty feeding and develop poor muscle tone, and starting about … Continue reading →

ScienceDaily (June 18, 2012) Chicagoan Ieshea Thomas is the first Midwest patient to receive a successful stem cell transplant to cure her sickle cell disease without chemotherapy in preparation for the transplant. University of Illinois Hospital & Health Sciences System physicians performed the procedure using medication to suppress her immune system and one small dose of total body radiation right before the transplant. The transplant technique is relatively uncommon and is a much more tolerable treatment for patients with aggressive sickle cell disease who often have underlying organ disease and other complications, says Dr. Damiano Rondelli, professor of medicine at UIC, who performed Thomas's transplant. The procedure initially allows a patient's own bone marrow to coexist with that of the donor. Since the patient's bone marrow is not completely destroyed by chemotherapy or radiation prior to transplant, part of the immune defense survives, lessening the risk of infection. The goal is for the transplanted stem cells to gradually take over the bone marrow's role to produce red blood cells -- normal, healthy ones. Thomas, 33, had her first sickle cell crisis when she was just 8 months old. Her disease became progressively worse as an adult, particularly after the birth … Continue reading →

CLEVELAND, Ohio--As the number of children diagnosed with autism continues to grow, the number of families seeking information about treatment, education, job placement and housing is skyrocketing. And they're willing to pay for sound advice. This week many of them will gather in Cleveland for a two-day conference run by Milestones Autism Organization, a Beachwood-based education group formed in 2003 to provide scientific information for parents on how to best help their autistic children. In the 10th year of the conference, the organizers have expanded to a two-day format for the first time, have moved to a larger venue and expect 900 attendees. The conference isn't free: It costs $125 for family members, and $85 for individuals with autism or Asperger's syndrome. But participants, who numbered nearly 900 last year, seem to think it's well worth it. Ilana Hoffer Skoff, executive director of Milestones, said the conference is an opportunity for parents, educators and therapists to network and to gather evidence-based information on treatments, educational tools, communication strategies and behaviors. Hoffer Skoff, the mother of a teenage daughter with autism, started Milestones with another parent in 2003 to improve services and find people who were trained to work with their … Continue reading →